Resultats de la cerca - Mattia Alberto Di Civita
- Mostrar 1 - 2 resultats de 2
-
1
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis per Michela Roberto, Mattia Alberto Di Civita, Daniele Marinelli, Andrea Torchia, Nertila Cara, Giulia Maltese, Iolanda Speranza, Daniele Santini
Publicat 2025Revisão -
2
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and... per Daniele Marinelli, Filippo Tommaso Gallina, Sergio Pannunzio, Mattia Alberto Di Civita, Andrea Torchia, Raffaele Giusti, Alain Gelibter, Michela Roberto, Monica Verrico, Enrico Melis, Riccardo Tajè, Fabiana Letizia Cecere, Lorenza Landi, Paola Nisticò, Nicla Porciello, Mario Occhipinti, Marta Brambilla, Patrick M. Forde, Stephen V. Liu, Andrea Botticelli, Silvia Novello, Gennaro Ciliberto, Enrico Cortesi, Francesco Facciolo, Federico Cappuzzo, Daniele Santini
Publicat 2023Revisão
Eines de cerca:
Matèries relacionades
Biology
Cancer
Internal medicine
Medicine
Oncology
A549 cell
Adverse effect
Atezolizumab
Breast cancer
Chemotherapy
Cisplatin
Clinical endpoint
Clinical trial
Confidence interval
Environmental health
Gene
Genetics
Hazard ratio
Homologous recombination
Immunotherapy
Lung cancer
Meta-analysis
Neoadjuvant therapy
PARP inhibitor
Paleontology
Pembrolizumab
Perioperative
Poly ADP ribose polymerase
Polymerase
Population